Home GU Oncology Now GU Oncology Now Picks

GU Oncology Now Picks

Cell-Free DNA NGS Yields Low Detection in Metastatic ccRCC

Certain Risk Factors Could Prevent Unnecessary Biopsy in PI-RADS 3 Lesions

Testicular Cancer Survivors at Increased Risk for Skin Cancer

Active Surveillance Vs. Curative Treatment for Prostate Cancer: No Difference in Patient Anxiety, Depression...

Gemcitabine Plus Docetaxel: An Effective Alternative to BCG Therapy for High-Risk NMIBC

Patients With Prostate Cancer Usually Share Genetic Testing Results With Family Members

Nivolumab Plus Ipilimumab, Cabozantinib Plus Nivolumab Get Top Scores for Emerging RCC Therapeutics

Higher APOA1 mRNA Levels Linked to Lower OS in Patients With KIRC

PSA Decreases or Fluctuations During PSMA-Targeted Therapy Linked to Prolonged Survival in mCRPC

No Impact of Germline Variants on RFS, PFS in NMIBC Patients Receiving Bacillus Calmette-Guerin

Load more
Subscribe to RSS